Related Experiment Video
Updated: Dec 5, 2025
Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
Spontaneous Intraparenchymal Hepatic Hemorrhage as a Sequela of COVID-19
Saravgunjit Singh Daid1, Adderly D Toribio1, Seetha Lakshmanan1
1Internal Medicine, Roger Williams Medical Center, Providence, USA.
Insights
Coronavirus disease 2019 (COVID-19) can cause intrahepatic hemorrhage due to endothelialitis. N-acetylcysteine (NAC) may be a potential treatment for this liver complication.
Area of Science:
- Hepatology
- Infectious Diseases
- Vascular Biology
Background:
- Coronavirus disease 2019 (COVID-19) presents with diverse clinical manifestations.
- Endothelialitis is increasingly recognized as a pathological feature of COVID-19.
- Intrahepatic hemorrhage is a rare but serious potential complication of COVID-19.
Observation:
- A case of intrahepatic hemorrhage in a COVID-19 patient is presented.
- The hemorrhage is hypothesized to be a consequence of COVID-19-induced endothelialitis.
- Clinical presentation and diagnostic findings are detailed.
Findings:
- The patient diagnosed with COVID-19 experienced intrahepatic hemorrhage.
- Endothelialitis, a known feature of COVID-19, is implicated as the cause.
- Further research is needed to confirm the causal link and understand the pathophysiology.
Implications:
- This case highlights potential hepatic complications of COVID-19.
- N-acetylcysteine (NAC) is proposed as a potential therapeutic agent for managing COVID-19-related liver injury.
- Increased awareness among clinicians regarding liver involvement in COVID-19 is crucial.
Abstract:
Patients with coronavirus disease 2019 (COVID-19) have been presenting with varying signs and symptoms. The medical community is being updated with new knowledge about this disease daily. We present a case of intrahepatic hemorrhage in a patient diagnosed with C0VID-19 which we believe was caused by endothelialitis, which is a characteristic feature of COVID-19. Nevertheless, further continued studies are required to validate this point. We aim to educate the medical community about the possible complications by COVID-19 in the liver and highlight that N-acetylcysteine (NAC) may be a useful option in these cases.
